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Abstract
Cardiovascular diseases are main cause of morbidity and mortality in the Western World.  Cardiovascular disease increases in its prevalence with age and the burden 
of this condition is set to increase with an Ageing global population. There are many factors that impact cardiovascular disease risk. The aim of this brief commentary 
is to explore some of these factors; specifically, we will examine the role of social status, nutrition and, psychological stress in modulating cardiovascular disease risk. 
Our aim is to emphasise the multidimensional nature of this condition and to stress that a more complete understanding of the mechanisms which underpin its 
pathology can only be achieved by adopting an integrated approach which treats the progression of this disease in a more holistic fashion.  
Introduction
The global population is gradually ageing. With an ageing population 
there comes an increase in the prevalence age related disease. Of the 
diseases of ageing those conditions of the heart and circulatory system, 
which are collectively known as cardiovascular disease (CVD), are the 
most common. The growth in prevalence of CVD has implications for 
governments, health professionals, and those likely to suffer from the 
condition as the cost of treating and caring for individuals with CVD is 
set to escalate. This will no doubt impact the health and well-being of 
older individuals whose treatment may be curtailed or compromised 
due to the financial burden of caring for them. This problem may 
prevent older people from benefitting from the healthy extra few years 
of life which they would otherwise gain. Therefore, it is logical that 
a better understanding of the risk factors that underpin CVD risk is 
achieved. Risk factors can be broadly categorised into extrinsic and 
intrinsic. Extrinsic factors include physical inactivity, social status, 
the environment, nutrition, and psychological stress. Intrinsic factors 
include genetic/epigenetic status, perturbations in physiological 
systems, such as lipid biomarkers, blood pressure and a variety of 
hormones. In this short communication we will very briefly examine 
some of these risk factors and we will emphasise that a combination 
of factors is ultimately responsible for modulating CVD risk. Our 
overarching aim is to encourage a more integrated interpretation of 
ageing and the role it has to play in CVD progression [1-3]. 
The role of dietary lipids
Diet is a significant adaptable determinant of healthy ageing. 
In recent years a wide variety of studies have scrutinised micro and 
macronutrients in order to find the optimal dietary balance that 
minimise the insidious effects of ageing. In particular a large number 
of studies have examined the effect of dietary lipids on CVD risk, due 
to their intimate relationship with lipid metabolism. The relationship 
between dietary cholesterol (DC) and CVD is a controversial one. For 
instance, certain studies have shown  that DC is a risk factor for CVD, 
while others have found no association (reviewed in [4]).  Part of the 
problem is that individuals vary significantly in their responses to DC. 
Based on our findings from whole-body mathematical modelling [5] 
we are of the opinion that these inter-individual variations are at least 
partly due to the heterogeneity in cholesterol absorption, that exists 
among healthy individuals [6]. Despite the fact that the role of DC in 
CVD remains controversial; there is less ambiguity when it comes to 
examining the metabolic impact of dietary saturated fatty acids (SFAs) 
have on CVD risk. SFAs are widely regarded to increase CVD risk, 
due to their effect on low density lipoprotein cholesterol (LDL-C) 
(reviewed in [7]). Conversely n-6 and n-3 polyunsaturated fatty acids 
are inversely related to CVD mortality [8]. Thus, CVD risk from diet 
can in part be assumed to be a combination of the metabolic effects 
of these macronutrients. Studying their molecular, biochemical, 
physiological and whole body effects requires integrated frameworks 
which are capable of dealing with this level of complexity [9]. 
Is dietary fibre being overlooked? 
Recently a comprehensive meta-analysis found that total dietary 
fibre intake is inversely correlated with risk of CVD [10]. This 
relationship could be modulated by the favourable effects dietary fibre 
has on blood lipid profile.  For example, a previous meta-analysis 
found a correlation between the consumption of soluble fibre and a 
decrease in LDL-C levels [11]. This meta-analysis of 67 controlled trials 
found that 3 g of soluble fibre from oats (3 daily servings of oatmeal, 
28 g each) can decrease total and LDL-C significantly. Perhaps we 
have overlooked dietary fibre lately as the blood cholesterol lowering 
focus has been on plant sterols.  Plant sterols are naturally occurring 
compounds, which are structurally related to cholesterol, differing 
only in the structure of their side chains [12]. Consumption of 1.8-
2.0 g/day of plant sterols has in recent years been shown to lower both 
total and LDL-C concentrations by 10%-15% in a variety of different 
population groups [13].  Normal daily intakes of plant sterols are in 
the range 170–360 mg/day [14]. Several studies have indicated that 
plant sterols reduce cholesterol absorption by 30%-50%, although the 
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precise biological mechanism(s) responsible for this remains unclear. 
However, a wide variety of processes have been suggested, including 
the interference of trans-intestinal cholesterol excretion (reviewed in 
[15]).
Physical activity
Physical activity (PA) frequently decreases with age due to a 
reduction in the pace of life. However, the importance of staying 
physically active cannot be underestimated. There is significant 
evidence, from a broad range of studies which suggest an inverse 
relationship between PA and CVD risk.  This amelioration could be 
induced by an improvement in blood lipid profile.  For  example,  in  a 
classic meta-analysis Leon et al. (2001) reviewed 51 human intervention 
studies examining the effects of at least 12 weeks of PA on blood 
lipid profile in men and women from 1987-2000 [16]. The authors 
reported a lipid profile improvement in response to PA in nearly half 
of the studies reviewed. It has also been suggested that lipid profile is 
improved through the activation of lipoprotein lipase a key enzyme 
involved in fatty acid metabolism, which stimulates the clearance of 
triglyceride-rich lipoproteins to supply free fatty acids to exercising 
muscle.  In our opinion there is a growing need to investigate the dose-
response relationship between physical activity and CHD/CVD risk 
in older people. If this relationship could be further understood then 
appropriate PA regimes could be tailored for older people based on 
individual circumstance. 
How does social status impact CVD risk?
It has long been accepted that inequalities in social status have an 
impact on CVD risk. Within the European Union (EU) significant gaps 
persist in health equality. Individuals from lower social backgrounds 
have a significantly reduced life expectancy. According to the most 
recent available demographic data, a child born in England or Wales 
between 2010 and 2012 can expect to live to 79.1 years if male and 89.2 
years if female [17]. However, males born within the Scottish city of 
Glasgow during the same period have a life expectancy of 72.6 years [18]. 
Such differences are not confined to the UK, the EU Working Group 
on Socioeconomic Inequalities in Health; compared 13 European 
countries based on their inequalities with respect to morbidity and 
mortality [19]. This study found that relative inequalities in premature 
mortality have continued to rise in most European countries, and since 
the 1990s, the contrast between the South (with smaller inequalities) 
and the East (with larger inequalities) has become increasingly 
significant. Higher social status is not universally beneficial. In 
developing countries, higher social status has been associated with an 
increased CVD risk factor profile [20].  This is potentially due to the 
adoption of a westernized lifestyle which is characterized by physical 
inactivity, smoking and poor diet. It is likely this is a contributing 
factor to the emergence of the CVD epidemic that has taken place in 
developing countries in the last half century. 
Stress and cortisol 
Exposure to psychological stress also contributes to CVD risk. 
The impact of psychological stress on CVD health could be mediated 
by hormonal changes which have been implicated in perturbing lipid 
metabolism, (reviewed in [21]). Cortisol is a glucocorticoid hormone 
whose release is provoked by stress. The hormone is synthesised in 
the adrenal gland and released from the pituitary. It acts ubiquitously 
throughout the body by binding to glucocorticoid receptors where it 
performs a wide variety of roles, including acting as an antagonist to 
insulin by provoking gluconeogenesis; it also promotes the breakdown 
of lipids, and a wide variety of other metabolites [22]. Despite the 
essential role of cortisol in maintaining the normal physiology of the 
body after stress, continual exposure to cortisol has been suggested to 
disrupt normal metabolism. For example, cortisol has been implicated 
as a pathophysiological mediator in idiopathic obesity [23] and has 
also been associated with an unfavourable lipid profile in women 
[24].  Cortisol excess also impacts a broad range of other parameters of 
cardiovascular health [25]. Recently, we used mathematical modelling 
to show that both acute and chronic levels of cortisol have a profound 
impact on brain ageing. It would be worthwhile adopting a similar 
framework to explore the long term impact of elevated cortisol on CVD 
risk [26]. 
Genetic and epigenetic factors
A plethora of genetic polymorphisms have been associated with 
CVD risk [27]. If we focus on lipid metabolism mutations in cholesteryl 
ester transfer protein, an enzyme that is essential for reverse cholesterol 
transport, could lessen the risk of developing ischemic heart disease 
[28]. Similarly, mutations in the gene coding for Apolipoprotein E have 
an established association with CVD risk. apo E is a protein associated 
with chylomicrons, very low density lipoproteins, and high density 
lipoprotein-cholesterol. It acts as a ligand for the LDL receptor. The 
apo E locus has 3 common alleles, E4, E3, and E2. apo E deficiency 
results in high levels of cholesterol-enriched lipoproteins, with the apo 
E4 variant having the most significant impact on lipid metabolism, due 
to its association with elevated LDL-C [29].  
Epigenetic factors have also been implicated in the progression 
of CVD. Epigenetics is the study of heritable alterations in gene 
expression that occur without changes to the DNA sequence. Epigenetic 
mechanisms include DNA methylation and histone modifications, with 
the former being best understood.  DNA methylation acts as a marker 
during embryonic development, as methyl groups act as indicators for 
foetal development [30]. Once these tissue specific methylation patterns 
have been established, their maintenance becomes crucial. The primary 
reason for this is that throughout life DNA methylation plays a vital 
role in the regulation of gene expression  [31]. However, during ageing 
DNA methylation patters alter significantly [32]. The consequences 
of this are that age related changes to methylation patterns have been 
associated with a variety of diseases  including CVD [33].  For instance, 
a recent study found an association between DNA methylation and a 
number of genes implicated in CVD [34]. 
Conclusions
The ultimate goal of research into healthy ageing should be to 
understand the ageing process to the extent where novel strategies 
that delay or even prevent the onset of conditions such as CVD can be 
implemented. Developing novel strategies will require a more integrated 
understanding of the ageing process and a holistic appreciation of the 
wide variety of both intrinsic and extrinsic factors that contribute to 
CVD risk.  How successful we are in implementing these interventions 
may ultimately determine the quality of life in very old age. In so doing 
we may not rid humanity of age related disease, but may significantly 
mitigate its impact.
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